Intervention
Cryoablation
ClinicalTrials.gov intervention label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov intervention label, found in 31 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
31 shownPost-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)NCT07629206 · 2026-07-17
RECRUITINGImproving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)NCT07567027 · 2026-06-17
RECRUITINGSafety and Efficacy Evaluation of Cryoablation in the Treatment of Ground-Glass NodulesNCT07232433 · 2025-11-21
RECRUITINGPercutaneous Cryoablation of Low-risk Early Breast CancerNCT06300125 · 2024-04-15
RECRUITINGToripalimab Combined With Cryoablation for First-line Oligo-progression in Driver-negative Advanced NSCLCNCT06127303 · 2024-04-02
RECRUITINGCryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesNCT06265350 · 2024-02-02
RECRUITINGA Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast CancerNCT06246968 · 2024-01-29
RECRUITINGCOOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical PatientsNCT05972343 · 2023-07-26
RECRUITINGCryoablation as a Minimally Invasive Alternative to Surgery for Managing Ductal Carcinoma In SituNCT05218044 · 2021-11-01
RECRUITINGCryoablation in Combination (or Not) With Pembrolizumab and Pemetrexed-carboplatin in 1st-line Treatment for Patients With Metastatic Lung AdenocarcinomaNCT04339218 · 2020-08-28
RECRUITINGCRYO-TOUCH: Cryoablation of the Primary Breast Tumor in Metastatic Breast CancerNCT07676344 · 2026-10-01
NOT_YET_RECRUITINGGrouping Immune-modulation With Cryoablation (LOGIC) for Breast CancersNCT05806385 · 2026-03-01
NOT_YET_RECRUITINGEfficacy and Safety of Combination Therapy of Sintilimab and Chemotherapy With Cryoablation in NSCLCNCT06483009 · 2024-10-01
NOT_YET_RECRUITINGCryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung CancerNCT06580665 · 2024-09-01
NOT_YET_RECRUITINGFreezIng bReaST Cancer in Brazil: a Before-after StudyNCT05398497 · 2022-09-15
UNKNOWNPilot Study to Define the Immune Response Following Cryoablation of Invasive Breast CancerNCT03523299 · 2018-05-22
WITHDRAWNStudy of Core Needle Biopsy and Cryoablation of an Enlarging Tumor in Patients With Metastatic Lung Cancer and Metastatic Melanoma Receiving Post-progression Immune Checkpoint Inhibitor TherapyNCT03290677 · 2018-01-17
COMPLETEDCryoablation for Obesity ManagementNCT03092778 · 2017-06-13
COMPLETEDAblation of Atrial Fibrillation in Heart Failure PatientsNCT03062241 · 2017-01-23
UNKNOWNA Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)NCT02821754 · 2016-07-05
COMPLETEDA Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast CancerNCT02833233 · 2016-06-01
COMPLETEDEvaluation of Percutaneous Treatment by Cryoablation of Unifocal Invasive Breast Carcinoma in Menopausal Women With Indication of LumpectomyNCT02576106 · 2016-02-01
COMPLETEDStudy of Cryoablation for Metastatic Lung TumorsNCT01957787 · 2014-04-10
COMPLETEDIncreased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer PatientsNCT02018419 · 2014-03-01
WITHDRAWNAnti-Tumor Immunity Induced by Cryoablation of Invasive Breast CancersNCT01856036 · 2013-04-01
TERMINATEDCryoablation for Invasive Breast Carcinoma Following Neoadjuvant TherapyNCT01388777 · 2012-01-24
TERMINATEDSafety and Efficacy of Cryoablation for Metastatic Lung TumorsNCT01307501 · 2012-01-04
COMPLETEDPre-Operative, Single-Dose Ipilimumab and/or Cryoablation in Early Stage/Resectable Breast CancerNCT01502592 · 2011-12-01
COMPLETEDExperimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV CancerNCT01065441 · 2010-12-01
COMPLETEDProstate Conformal CryotherapyNCT00877682 · 2009-04-06
COMPLETEDCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerNCT00499733 · 2007-06-01
TERMINATEDCommon conditions
Breast Cancer9Metastatic Breast Cancer3Non-small Cell Lung Cancer3Hepatocellular Carcinoma2Lung Cancer2Prostate Cancer2Triple Negative Breast Cancer2Atrial Fibrillation1Bevacizumab1Bile Duct Cancer1Biliary Tract Neoplasms1Breast Cancer Stage IV1Breast Neoplasms1Cadonilimab1Cancer1Cancer of the Breast1Carcinoma, Ductal, Breast1Cholangiocarcinoma1Colorectal Cancer1Cryoablation1Cryotherapy Effect1Ductal Carcinoma in Situ1Invasive Adenocarcinoma of the Breast1Invasive Ductal Carcinoma, Breast1Liver Cancer1
Leading sponsors
Memorial Sloan Kettering Cancer Center
3
Shanghai Chest Hospital
3
Boston Scientific Corporation
2
M.D. Anderson Cancer Center
2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2
Centre Leon Berard
1
Emory University
1
European Institute of Oncology
1
Glendale Adventist Medical Center d/b/a Adventist Health Glendale
1
Hospices Civils de Lyon
1
Hospital do Coracao
1
IceCure Medical Ltd.
1
Institut Bergonié
1
Massachusetts General Hospital
1
Medical University of Silesia
1
Trial status mix
COMPLETED10
RECRUITING10
NOT_YET_RECRUITING4
TERMINATED3
UNKNOWN2
WITHDRAWN2
Phase mix
NA18
PHASE26
PHASE15
EARLY_PHASE11
PHASE31
PHASE41
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.